CLINICAL TRIALS PROFILE FOR TROPHAMINE
✉ Email this page to a colleague
All Clinical Trials for TROPHAMINE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00005775 ↗ | Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants | Completed | National Center for Research Resources (NCRR) | Phase 3 | 1999-07-01 | This large multicenter double-masked clinical trial tested whether supplementation of standard neonatal parenteral nutrition with glutamine would reduce the risk of death or late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm) infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or TrophAmine supplemented with glutamine before 72 hours and continued until the infants are tolerating full enteral feedings. |
| NCT00005775 ↗ | Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants | Completed | NICHD Neonatal Research Network | Phase 3 | 1999-07-01 | This large multicenter double-masked clinical trial tested whether supplementation of standard neonatal parenteral nutrition with glutamine would reduce the risk of death or late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm) infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or TrophAmine supplemented with glutamine before 72 hours and continued until the infants are tolerating full enteral feedings. |
| NCT00005889 ↗ | Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion | Unknown status | Baylor College of Medicine | N/A | 1999-10-01 | RATIONALE: Very low birth weight infants have problems maintaining normal blood sugar levels. Gluconeogenesis is the production of sugar from amino acids and fats. The best combination of amino acids, fat, and sugar to help very low birth weigh infants maintain normal blood sugar levels is not yet known. PURPOSE: Clinical trial to study how very low birth weight infants break down amino acids, fat, and sugar given by intravenous infusion, and the effect of different combinations of nutrients on the infants' ability to maintain normal blood sugar levels. |
| NCT00005889 ↗ | Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion | Unknown status | National Center for Research Resources (NCRR) | N/A | 1999-10-01 | RATIONALE: Very low birth weight infants have problems maintaining normal blood sugar levels. Gluconeogenesis is the production of sugar from amino acids and fats. The best combination of amino acids, fat, and sugar to help very low birth weigh infants maintain normal blood sugar levels is not yet known. PURPOSE: Clinical trial to study how very low birth weight infants break down amino acids, fat, and sugar given by intravenous infusion, and the effect of different combinations of nutrients on the infants' ability to maintain normal blood sugar levels. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TROPHAMINE
Condition Name
Clinical Trial Locations for TROPHAMINE
Trials by Country
Clinical Trial Progress for TROPHAMINE
Clinical Trial Phase
Clinical Trial Sponsors for TROPHAMINE
Sponsor Name
